Drug intelligence / Profile preview

Regeneris BioKnee

Development stage
Unknown
Lead developer
Regeneris Medical
Modality
Stem Cell Therapies → Cell Therapies, Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intraarticular
01

Overview

Regeneris BioKnee is a regenerative medicine procedure developed by Regeneris Medical as an alternative to total knee replacement for patients with degenerative knee disease or chronic knee pain. The protocol involves an autologous combination of adipose-derived stem and progenitor cells and platelet-rich plasma (PRP). The procedure is performed on an outpatient basis: fat is extracted via a minimally invasive process to harvest stem cells (yielding approximately 10 to 40 million cells per treatment), and blood is drawn to process PRP. These biological components are then injected directly into the injured knee joint under local anesthesia. The treatment aims to activate the body's natural healing processes to repair joint tissue, increase range of motion, and reduce pain, with effects reported to last between 7 to 10 years.

Brand names
Regeneris BioKneeBioKnee

Beyond the preview

Go deeper on Regeneris BioKnee.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regeneris BioKnee.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call